Raj K. Maturi
NEW ORLEANS — No overall difference was found in mean visual acuity gains in patients treated with Lucentis alone or with Lucentis plus dexamethasone, according to a speaker.
“We wanted to evaluate if a combination treatment would be superior to anti-VEGF treatment alone for patients with persistent edema,” Raj K. Maturi, MD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting, where he delivered results of the Diabetic Retinopathy Clinical Research Network Protocol U trial.
“We enrolled 236 eyes, gave them three
Uncategorized